Trials in rheumatoid arthritis: choosing the right outcome measure when minimal disease is achievable

被引：10

作者：

Felson, David T. ^{[1
]}

Zhang, Bin ^{[1
]}

Siegel, Jeffrey N. ^{[2
]}

机构：

[1] Boston Univ, Sch Med, Clin Epidemiol Unit, Boston, MA 02118 USA

[2] US FDA, Silver Spring, MD USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2008年 / 67卷 / 05期

关键词：

D O I：

10.1136/ard.2007.079632

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：580 / 583

页数：4

共 20 条

[1]

Anderson JJ, 2002, ARTHRITIS RHEUM-US, V46, pS520

[2] Comparison of rheumatoid arthritis clinical trial outcome measures - A simulation study [J].

Anderson, JJ ;

Bolognese, JA ;

Felson, DT .

ARTHRITIS AND RHEUMATISM, 2003, 48 (11) :3031-3038

[3]

[Anonymous], 1986, LANCET, V1, P397

[4]

[Anonymous], CARDIOVASCULAR DIS S

[5] The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment [J].

Breedveld, FC ;

Weisman, MH ;

Kavanaugh, AF ;

Cohen, SB ;

Pavelka, K ;

van Vollenhoven, R ;

Sharp, J ;

Perez, JL ;

Spencer-Green, GT .

ARTHRITIS AND RHEUMATISM, 2006, 54 (01) :26-37

[6] Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison [J].

Combe, B. ;

Codreanu, C. ;

Fiocco, U. ;

Gaubitz, M. ;

Geusens, P. P. ;

Kvien, T. K. ;

Pavelka, K. ;

Sambrook, P. N. ;

Smolen, J. S. ;

Wajdula, J. ;

Fatenejad, S. .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (10) :1357-1362

[7] The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial [J].

Emery, P ;

Fleischmann, R ;

Filipowicz-Sosnowska, A ;

Schechtman, J ;

Szczepanski, L ;

Kavanaugh, A ;

Racewicz, AJ ;

Van Vollenhoven, RF ;

Li, NF ;

Agarwal, S ;

Hessey, EW ;

Shaw, TM .

ARTHRITIS AND RHEUMATISM, 2006, 54 (05) :1390-1400

[8]

Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI 10.1002/art.23364

[9] Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial [J].

Grigor, C ;

Capell, H ;

Stirling, A ;

McMahon, AD ;

Lock, P ;

Vallance, R ;

Kincaid, W ;

Porter, D .

LANCET, 2004, 364 (9430) :263-269

[10] Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis - An investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study [J].

Hetland, Merete Lund ;

Stengaard-Pedersen, Kristian ;

Junker, Peter ;

Lottenburger, Tine ;

Ellingsen, Torkell ;

Andersen, Lis Smedegaard ;

Hansen, Lb ;

Skjodt, Henrik ;

Pedersen, Jens Kristian ;

Lauridsen, Ulrik Birk ;

Svendsen, Anders ;

Tarp, Ulrik ;

Podenphant, Jan ;

Hansen, Gert ;

Lindegaard, Hanne ;

De Carvalho, Anselmo ;

Ostergaard, Mikkel ;

Horslev-Petersen, Kim .

ARTHRITIS AND RHEUMATISM, 2006, 54 (05) :1401-1409

← 1 2 →